We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.85B
AUM Growth
-$153M
Cap. Flow
-$306M
Cap. Flow %
-7.96%
Top 10 Hldgs %
17.74%
Holding
705
New
68
Increased
289
Reduced
229
Closed
52

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$22.5M
2
AET
Aetna Inc
AET
+$21.5M
3
JNJ icon
Johnson & Johnson
JNJ
+$20.4M
4
ADI icon
Analog Devices
ADI
+$19.4M
5
CMI icon
Cummins
CMI
+$17.3M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$43.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$40.1M
3
ABBV icon
AbbVie
ABBV
+$37.1M
4
GILD icon
Gilead Sciences
GILD
+$24.2M
5
PH icon
Parker-Hannifin
PH
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Financials 13.06%
3 Technology 10.24%
4 Consumer Staples 10.19%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDNY
501
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$654K 0.02%
11,567
– –
RNR icon
502
RenaissanceRe
RNR
$13.7B
$651K 0.02%
5,539
+440
+9% +$50.5K
LRMR icon
503
Larimar Therapeutics
LRMR
$416M
$647K 0.02%
9,000
– –
BCR
504
DELISTED
CR Bard Inc.
BCR
$646K 0.02%
2,745
+244
+10% +$53K
HAS icon
505
Hasbro
HAS
$12.6B
$645K 0.02%
7,685
– –
CLVS
506
DELISTED
Clovis Oncology, Inc.
CLVS
$645K 0.02%
47,000
+15,000
+47% +$219K
IQV icon
507
IQVIA
IQV
$34.7B
$640K 0.02%
9,790
+1,916
+24% +$128K
PTC icon
508
PTC
PTC
$13.7B
$639K 0.02%
17,000
+4,300
+34% +$154K
AXS icon
509
AXIS Capital
AXS
$8.59B
$638K 0.02%
11,602
+692
+6% +$37.5K
LH icon
510
Labcorp
LH
$24.3B
$638K 0.02%
5,699
-20,228
-78% -$2.18M
DISH
511
DELISTED
DISH Network Corp.
DISH
$633K 0.02%
12,086
-5,082
-30% -$248K
EG icon
512
Everest Group
EG
$15.2B
$632K 0.02%
3,460
+30
+0.9% +$5.51K
CPB icon
513
Campbell Soup
CPB
$6.51B
$631K 0.02%
+9,486
New +$595K
TCON
514
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$626K 0.02%
715
-100
-12% -$133K
MKL icon
515
Markel Group
MKL
$25B
$619K 0.02%
+650
New +$605K
AMBA icon
516
Ambarella
AMBA
$2.99B
$610K 0.02%
12,000
– –
FRT icon
517
Federal Realty Investment Trust
FRT
$10.9B
$598K 0.02%
3,610
-3,119
-46% -$485K
ESS icon
518
Essex Property Trust
ESS
$18.9B
$597K 0.02%
+2,619
New +$585K
CHD icon
519
Church & Dwight Co
CHD
$23.1B
$591K 0.02%
11,490
– –
CAJ
520
DELISTED
Canon, Inc.
CAJ
$584K 0.02%
20,400
– –
GBT
521
DELISTED
Global Blood Therapeutics, Inc.
GBT
$581K 0.02%
+35,000
New +$706K
IMO icon
522
Imperial Oil
IMO
$62.1B
$565K 0.01%
17,945
+3,507
+24% +$111K
PBCT
523
DELISTED
People's United Financial Inc
PBCT
$558K 0.01%
+38,028
New +$590K
CA
524
DELISTED
CA, Inc.
CA
$558K 0.01%
16,994
+1,801
+12% +$56.4K
PRTK
525
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$556K 0.01%
+40,000
New +$589K
19 20
21
22 23

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2016 Portfolio in Review

As of Q2 2016, Candriam SCA held 705 positions worth $3.85B, down 3.8% from $4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA withdrew a net $306M in Q2 2016, closing 52 positions and reducing 229 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $9.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in NiSource worth $14.5M.

  • Candriam SCA's largest Q2 2016 buy was NiSource: 547,430 shares worth $14.5M.
  • Candriam SCA added most to Abbott in Q2 2016, an estimated $22.5M increase.
  • Candriam SCA's biggest Q2 2016 reduction was Intel, cutting an estimated $43.9M.
  • Candriam SCA fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $9.2M.
  • Candriam SCA's ten largest holdings make up 18% of its $3.85B portfolio in Q2 2016.
  • Candriam SCA opened 68 new positions and closed 52 in Q2 2016.
  • Candriam SCA's portfolio value fell 3.8% quarter-over-quarter to $3.85B.

Based on Candriam SCA's 13F filing for Q2 2016, filed 26 Jul 2016.